BioSpace News Archive

Lonza Leads Market with Large and HLA-Typed CD34+ Cell Lots for Efficient Humanized Mouse Model Development

Lonza has expanded its renowned human stem cell offerings to provide human cord blood CD34+ hematopoietic stem cells (CB-CD34+ HSCs) in large batch sizes, meeting a critical and rapidly expanding market need.

March 15, 2022
·
5 min read
Job Trends

Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older Adults

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the companies have submitted an application to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of an additional booster dose adults 65 years of age and older who have received an initial booster of any of the authorized or approved COVID-19 vaccines.

March 15, 2022
·
23 min read
Blood Group Typing Market to gain US$2.5 bn by the end of 2022, increasing pace of incidence chronic diseases to drive the market

Albany NY, United States: The blood group typing market is anticipated to flourish notably within the forecast period from 2017 to 2022.

March 15, 2022
·
5 min read